MEI Pharma Inc (MEIP)
2.78
-0.03
(-1.07%)
USD |
NASDAQ |
Nov 22, 14:59
MEI Pharma Total Assets (Quarterly): 27.75M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 27.75M |
| June 30, 2024 | 41.38M |
| March 31, 2024 | 71.26M |
| December 31, 2023 | 78.54M |
| September 30, 2023 | 101.25M |
| June 30, 2023 | 120.81M |
| March 31, 2023 | 134.19M |
| December 31, 2022 | 147.60M |
| September 30, 2022 | 163.58M |
| June 30, 2022 | 177.84M |
| March 31, 2022 | 194.43M |
| December 31, 2021 | 209.46M |
| September 30, 2021 | 176.35M |
| June 30, 2021 | 174.10M |
| March 31, 2021 | 186.12M |
| December 31, 2020 | 203.88M |
| September 30, 2020 | 214.01M |
| June 30, 2020 | 209.73M |
| March 31, 2020 | 96.62M |
| December 31, 2019 | 107.10M |
| September 30, 2019 | 68.92M |
| June 30, 2019 | 82.66M |
| March 31, 2019 | 85.93M |
| December 31, 2018 | 96.30M |
| September 30, 2018 | 94.75M |
| Date | Value |
|---|---|
| June 30, 2018 | 104.66M |
| March 31, 2018 | 37.40M |
| December 31, 2017 | 43.57M |
| September 30, 2017 | 48.03M |
| June 30, 2017 | 55.70M |
| March 31, 2017 | 59.89M |
| December 31, 2016 | 58.21M |
| September 30, 2016 | 61.04M |
| June 30, 2016 | 47.16M |
| March 31, 2016 | 50.93M |
| December 31, 2015 | 55.02M |
| September 30, 2015 | 59.07M |
| June 30, 2015 | 64.75M |
| March 31, 2015 | 71.60M |
| December 31, 2014 | 79.74M |
| September 30, 2014 | 42.92M |
| June 30, 2014 | 49.81M |
| March 31, 2014 | 56.04M |
| December 31, 2013 | 61.16M |
| September 30, 2013 | 32.62M |
| June 30, 2013 | 36.55M |
| March 31, 2013 | 24.95M |
| December 31, 2012 | 27.58M |
| September 30, 2012 | 4.355M |
| June 30, 2012 | 6.373M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
27.75M
Minimum
Sep 2024
214.01M
Maximum
Sep 2020
141.80M
Average
155.59M
Median
Total Assets (Quarterly) Benchmarks
| Avid Bioservices Inc | 334.64M |
| Evoke Pharma Inc | 14.15M |
| Revance Therapeutics Inc | 461.56M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.872M |
| Shareholders Equity (Quarterly) | 24.88M |